I would hope they would go with a JV and not a buyout when the time comes. When you think of the potential market of $30 billion, if they did a JV and you gave it a forward earnings of even 10, think of what this stock would be worth even with over 3 billion shares. If they got bought out, they would not even come close to that number. All this presumes the science does work which initial signs show it does. They just need to be able to hold on with finances and get through their bad governance until they get enough proof. This also does not include the platelet transfusion potential which would be billions of dollars. I know that is years down the road but would change everything.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.